#donanemab

[ follow ]
#fda-approval
www.nature.com
1 week ago
Medicine

Alzheimer's Drug with Modest Benefits Gets Green Light from FDA Advisers

Donanemab, a drug for Alzheimer's, gains unanimous approval for treating cognitive decline in early-stage patients but has limited effects and usage restrictions. [ more ]
www.npr.org
2 weeks ago
US news

FDA advisors strongly back new Alzheimer's drug, despite risks and limitations

FDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression. [ more ]
Nature
2 weeks ago
Medicine

Alzheimer's drug with modest benefits wins backing of FDA advisers

Donanemab slows cognitive decline in early Alzheimer's stages but lacks symptom reversal, raising concerns about its lasting effects. [ more ]
www.nature.com
1 week ago
Medicine

Alzheimer's Drug with Modest Benefits Gets Green Light from FDA Advisers

Donanemab, a drug for Alzheimer's, gains unanimous approval for treating cognitive decline in early-stage patients but has limited effects and usage restrictions. [ more ]
www.npr.org
2 weeks ago
US news

FDA advisors strongly back new Alzheimer's drug, despite risks and limitations

FDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression. [ more ]
Nature
2 weeks ago
Medicine

Alzheimer's drug with modest benefits wins backing of FDA advisers

Donanemab slows cognitive decline in early Alzheimer's stages but lacks symptom reversal, raising concerns about its lasting effects. [ more ]
morefda-approval
time.com
2 weeks ago
OMG science

The Next Potential Alzheimer's Drug Clears a Big Hurdle

Drug companies are making progress in Alzheimer's treatment with FDA panel's positive evaluation of Eli Lilly's donanemab. [ more ]
www.nytimes.com
2 weeks ago
Medicine

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's Drug

FDA advisors support Alzheimer's drug Donanemab despite risks. [ more ]
[ Load more ]